The effect of a novel probiotic on metabolic biomarkers in adults with prediabetes and recently diagnosed type 2 diabetes mellitus: study protocol for a randomized controlled trial
<h4>Background</h4> <p>Shifts in the gastrointestinal microbiome have been shown to contribute to the progression of metabolic diseases including prediabetes and type 2 diabetes mellitus. Research suggests that in-vivo modulation of the gut microbiome by specific probiotic microor...
| Автори: | , , , , , |
|---|---|
| Формат: | Journal article |
| Опубліковано: |
BioMed Central
2017
|